Pharmaceutical Packaging Market 2026
The Pharmaceutical Packaging Market was valued at in and is anticipated to reach by , at a CAGR of 0.095 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Pharmaceutical Packaging Market.
This report delivers a comprehensive overview of the Pharmaceutical Packaging Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmaceutical Packaging Market. The Pharmaceutical Packaging Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.
Pharmaceutical Packaging Market Scope:
By Type
This report delivers a comprehensive overview of the Pharmaceutical Packaging Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmaceutical Packaging Market. The Pharmaceutical Packaging Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Pharmaceutical Packaging Market.
This report delivers a comprehensive overview of the Pharmaceutical Packaging Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmaceutical Packaging Market. The Pharmaceutical Packaging Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.
Pharmaceutical Packaging Market Scope:
By Type
- Plastic Bottles
- Temperature-Controlled Packaging
- Ampoules
- Vials
- Prefilled Inhalers
- Blister Packs
- Pouches & Strip Packs
- Medication Tubes
- Jars & Canisters
- Cartridges
- Labels & Accessories
- Caps & Closures
- Medical Specialty Bags
- Prefilled Syringes
- Others
- Paper & Paperboards
- Plastics & Polymers
- Metals
- Glass
- Others
- Oral Drug Delivery Packaging
- IV Drugs Delivery Packaging
- Pulmonary Drug Delivery Packaging
- Injectable Packaging
- Transdermal Drug Delivery Packaging
- Topical Drug Delivery Packaging
- Nasal Drug Delivery Packaging
- Ocular Drug Delivery Packaging
- Veterinary Vaccines
- Drug Delivery
- Government Agencies
- Packaging Companies
- Manufacturer
- Berry Global Inc
- McKesson Corporation
- CCL Industries
- 3M
- Gerresheimer AG
- WestRock Company
- Amcor plc
- Mondi
- Thermo Fisher Scientific
- Robert Bosch GmbH(LIST NOT EXHAUSTIVE)
This report delivers a comprehensive overview of the Pharmaceutical Packaging Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmaceutical Packaging Market. The Pharmaceutical Packaging Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Increase Your Customer Base by 3X using our Partner Identification tool
- Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
- Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
- Prioritize partners by strategic fit rather than general capability.
- Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
- Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
- White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
- Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
- Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
- Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Type
3.2. Market Snippet by Raw Material
3.3. Market Snippet by Drug Delivery Mode
3.4. Market Snippet by Application
3.5. Market Snippet by End-User
3.6. Market Snippet by Region
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The extensive investments and growth of the pharmaceutical sector
4.1.1.2. XX
4.1.2. Restraints:
4.1.2.1. The stringent regulations in the pharmaceutical sector
4.1.2.2. XX
4.1.3. Opportunity
4.1.3.1. XX
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of COVID-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Plastic Bottles*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Temperature-Controlled Packaging
7.4. Ampoules
7.5. Vials
7.6. Prefilled Inhalers
7.7. Blister Packs
7.8. Pouches & Strip Packs
7.9. Medication Tubes
7.10. Jars & Canisters
7.11. Cartridges
7.12. Labels & Accessories
7.13. Caps & Closures
7.14. Medical Specialty Bags
7.15. Prefilled Syringes
7.16. Others
8. BY RAW MATERIAL
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material Segment
8.1.2. Market Attractiveness Index, By Raw Material Segment
8.2. Paper & Paperboards*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Plastics & Polymers
8.3.1. High-Density Polyethylene
8.3.2. Polyester
8.3.3. Polypropylene
8.3.4. Low-Density Polyethylene
8.3.5. Polyvinyl Chloride
8.3.6. Cyclic Olefin Copolymer
8.3.7. Polyethylene Terephthalate
8.3.8. Others
8.4. Metals
8.5. Glass
8.6. Others
9. BY DRUG DELIVERY MODE
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Delivery Mode Segment
9.1.2. Market Attractiveness Index, By Drug Delivery Mode Segment
9.2. Oral Drug Delivery Packaging*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. IV Drugs Delivery Packaging
9.4. Pulmonary Drug Delivery Packaging
9.5. Injectable Packaging
9.6. Transdermal Drug Delivery Packaging
9.7. Topical Drug Delivery Packaging
9.8. Nasal Drug Delivery Packaging
9.9. Ocular Drug Delivery Packaging
10. BY APPLICATION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application Segment
10.1.2. Market Attractiveness Index, By Application Segment
10.2. Veterinary Vaccines*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.2.2.1. Aquaculture Vaccines
10.2.2.2. Veterinary Vaccines
10.2.2.3. Feline Vaccines
10.2.2.4. Equine Vaccines
10.2.2.5. Livestock Vaccines
10.2.2.6. Porcine Vaccines
10.2.2.7. Poultry Vaccines
10.2.2.8. Canine Vaccines
10.2.2.9. Others
10.3. Drug Delivery
10.3.1. Oral Drugs
10.3.2. Topical
10.3.3. Ophthalmic
10.3.4. Nasal
10.3.5. Pulmonary
10.3.6. Transdermal
10.3.7. Others
11. BY END-USER
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.1.2. Market Attractiveness Index, By End-User
11.2. Government Agencies*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Packaging Companies
11.4. Manufacturer
12. BY REGION
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Delivery Mode
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. U.S.
12.2.8.2. Canada
12.2.8.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Delivery Mode
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. UK
12.3.8.3. France
12.3.8.4. Italy
12.3.8.5. Spain
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Delivery Mode
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Delivery Mode
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. Australia
12.5.8.5. Rest of Asia Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Delivery Mode
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13. COMPETITIVE LANDSCAPE
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. COMPANY PROFILES
14.1. Berry Global Inc*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Key Highlights
14.1.4. Financial Overview
14.2. McKesson Corporation
14.3. CCL Industries
14.4. 3M
14.5. Gerresheimer AG
14.6. WestRock Company
14.7. Amcor plc
14.8. Mondi
14.9. Thermo Fisher Scientific
14.10. Robert Bosch GmbH(*LIST NOT EXHAUSTIVE)
15. PREMIUM INSIGHTS
16. DATAM INTELLIGENCE
16.1. Appendix
16.2. About Us and Services
16.3. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Type
3.2. Market Snippet by Raw Material
3.3. Market Snippet by Drug Delivery Mode
3.4. Market Snippet by Application
3.5. Market Snippet by End-User
3.6. Market Snippet by Region
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The extensive investments and growth of the pharmaceutical sector
4.1.1.2. XX
4.1.2. Restraints:
4.1.2.1. The stringent regulations in the pharmaceutical sector
4.1.2.2. XX
4.1.3. Opportunity
4.1.3.1. XX
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of COVID-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Plastic Bottles*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Temperature-Controlled Packaging
7.4. Ampoules
7.5. Vials
7.6. Prefilled Inhalers
7.7. Blister Packs
7.8. Pouches & Strip Packs
7.9. Medication Tubes
7.10. Jars & Canisters
7.11. Cartridges
7.12. Labels & Accessories
7.13. Caps & Closures
7.14. Medical Specialty Bags
7.15. Prefilled Syringes
7.16. Others
8. BY RAW MATERIAL
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material Segment
8.1.2. Market Attractiveness Index, By Raw Material Segment
8.2. Paper & Paperboards*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Plastics & Polymers
8.3.1. High-Density Polyethylene
8.3.2. Polyester
8.3.3. Polypropylene
8.3.4. Low-Density Polyethylene
8.3.5. Polyvinyl Chloride
8.3.6. Cyclic Olefin Copolymer
8.3.7. Polyethylene Terephthalate
8.3.8. Others
8.4. Metals
8.5. Glass
8.6. Others
9. BY DRUG DELIVERY MODE
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Delivery Mode Segment
9.1.2. Market Attractiveness Index, By Drug Delivery Mode Segment
9.2. Oral Drug Delivery Packaging*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. IV Drugs Delivery Packaging
9.4. Pulmonary Drug Delivery Packaging
9.5. Injectable Packaging
9.6. Transdermal Drug Delivery Packaging
9.7. Topical Drug Delivery Packaging
9.8. Nasal Drug Delivery Packaging
9.9. Ocular Drug Delivery Packaging
10. BY APPLICATION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application Segment
10.1.2. Market Attractiveness Index, By Application Segment
10.2. Veterinary Vaccines*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.2.2.1. Aquaculture Vaccines
10.2.2.2. Veterinary Vaccines
10.2.2.3. Feline Vaccines
10.2.2.4. Equine Vaccines
10.2.2.5. Livestock Vaccines
10.2.2.6. Porcine Vaccines
10.2.2.7. Poultry Vaccines
10.2.2.8. Canine Vaccines
10.2.2.9. Others
10.3. Drug Delivery
10.3.1. Oral Drugs
10.3.2. Topical
10.3.3. Ophthalmic
10.3.4. Nasal
10.3.5. Pulmonary
10.3.6. Transdermal
10.3.7. Others
11. BY END-USER
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.1.2. Market Attractiveness Index, By End-User
11.2. Government Agencies*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Packaging Companies
11.4. Manufacturer
12. BY REGION
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Delivery Mode
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. U.S.
12.2.8.2. Canada
12.2.8.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Delivery Mode
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. UK
12.3.8.3. France
12.3.8.4. Italy
12.3.8.5. Spain
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Delivery Mode
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Delivery Mode
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. Australia
12.5.8.5. Rest of Asia Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Delivery Mode
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13. COMPETITIVE LANDSCAPE
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. COMPANY PROFILES
14.1. Berry Global Inc*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Key Highlights
14.1.4. Financial Overview
14.2. McKesson Corporation
14.3. CCL Industries
14.4. 3M
14.5. Gerresheimer AG
14.6. WestRock Company
14.7. Amcor plc
14.8. Mondi
14.9. Thermo Fisher Scientific
14.10. Robert Bosch GmbH(*LIST NOT EXHAUSTIVE)
15. PREMIUM INSIGHTS
16. DATAM INTELLIGENCE
16.1. Appendix
16.2. About Us and Services
16.3. Contact Us
